No Detail Found!

Assessment of serum fractalkine level as potential role for complications in splenectomized and non- splenectomized patients with β-thalassemia major

Author(s)
Ayat Saeed Awad Department of Chemistry, Faculty of Medicine, University of Jabir Ibn Hayyan, Najaf 54001, Iraq
Hanaa Addai Ali Department of Chemistry, Faculty of Science, University of Kufa, Najaf 54001, Iraq
Safaa Abdazahra Alwan Althalmi Al-Diwanyah Teaching Hospital, Al-Diwaniyh health directorate, Iraq
Abstract
Introduction: Thalassemia is a serious genetic blood related condition characterized by a lack of or malfunctioning hemoglobin in the RBCs. One of the most widespread inherited disorders is beta thalassemia (ß-TM). The high susceptibility to infection in these individuals' is related to high mortality and morbidity rates. Fractalkine is known as CX3C chemokine ligand 1 (CX3CL1), which contains a total of 371 amino acid, and participates in a number of functions, including repair of tissues after injury, immunological response during inflammation, and chemotaxis effet. Methodology: A case control study, containing sixty patients recognized as suffering from ß-TM, was conducted at Al Zahra Teaching Hospital, Najaf (Iraq). The patients were divided into two groups; splenectomized and nonsplenectomized patients. The thalassemia disease was enrolled in the “Thalassemia Unit”. Suitable statistical techniques were used to analyze the outcomes. Results: In the current study, a significant increase in serum level of CX3CL1 was found in patients with ß-TM, especially in splenectomized group (14.914 ± 2.636), (P = 0.01) and non-splenectomy (13.816 ± 2.686), (P = 0.05) group as compared with control group (12.26 ± 1.797).The linear regression analysis showed that a significant positive correlation in ferritin with serum CX3CL1 level in splenectomy patients with ß-TM group. ROC curve for CX3CL1 that might be diagnosis of patients with ß-TM with an AUC of 0.757 (95% CI: 0.623-0.890), sensitivity and specificity equally 75% and 83.3%. Conclusion: Increase level of CX3CL1 due to its interaction with CX3CR1 receptor may lead to buildup of inflammatory cells in the ß-TM patients, blocking CX3CL1 signaling may be helpful for patients with ß-TM. Abbreviations: AUC - Area Under Curve; ß-TM - Beta Thalassemia; ROC - Receiver Operating Characteristic UIBC Unsaturated Iron-Binding Capacity test; TIBC - Total Iron-Binding Capacity
Publication Details
Page(s) 495-500
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 27, Issue: 5, Year: 2023

Request the full text from PASTIC

Keywords
Thalassemia, ß thalassemia major, Fractalkine
References
Angastiniotis M,Lobitz S. .2019 .Thalassemias: an overview. Int J Neonatal Screen, 5(1) : 16.
Zafari M,Rad MTS,Mohseni F,Nikbakht N. β-Thalassemia,Major N. β-Thalassemia .2020 .Mortality and Morbidity: a Systematic Review Study. Hemoglobin, 45(1) : 1-4.
Genet Evol Infect .2020 .. , 85 : 104569.
Riopel M,Vassallo M,Ehinger E,Pattison J,Bowden K,Winkels H .2018 .-Fc treatment prevents atherosclerosis in Ldlr KO mice. Mol Metab, 11 : 89-101.
.2021 .. , 25(14) : 6963-75.
Sandnes M,Ulvik RJ,Vorland M .2008 .Reikvam Hyperferritinemia-a clinical overview. J Clin, 10(9) : .
.2019 .. , 10(3) : 1655-50.
Pandur E,Pap R,Jánosa G,Horváth A,Sipos K.,Fractalkine K. .2023 .Improves the Expression of Endometrium Receptivity-Related Genes and Proteins at Desferrioxamine-Induced Iron Deficiency in HEC-1A Cells. Int J Mol Sci, 24(9) : 7924.
.2020 .. - 206179, 73(5) : 278-282.
Al-Riyami AZ,Daar S. .2019 .Red cell alloimmunization in transfusiondependent and transfusion-independent beta thalassemia: A review from the Eastern Mediterranean Region (EMRO). Transfus Apher Sci, 58(6) : .
Nishimura M,Umehara H,Nakayama T,Yoneda O,Hieshima K,Kakizaki M .2002 .Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol, 168(12) : 6173-80.
Greiffo FR,Viteri-Alvarez V,Frankenberger M,Dietel D,OrtegaGomez A,Lee JS .2020 .-fractalkine axis drives kinetic changes of monocytes in fibrotic interstitial lung diseases. Eur Respir J, 55(2) : 00460-2019.
Cao Y,Fan Y,Li F,Hao Y,Kong Y,Chen C .2022 .Phenotypic and functional alterations of monocyte subsets with aging. Immun Ageing, 19(1) : 63.
Cormican S,Griffin MD .2021 .Fractalkine (CX3CL1) and its receptor CX3CR1: a promising therapeutic target in chronic kidney disease?. Front Immunol, 12 : 664202.
Ruze A,Zhao Y,Li H,Gulireba X,Li J,Lei D .2018 .Low shear stress upregulates the expression of fractalkine through the activation of mitogen-activated protein kinases in endothelial cells. Blood Coagul Fibrinolysis, 29(4) : 361.
Timasheva Y,Balkhiyarova Z,Avzaletdinova D,Rassoleeva I,Morugova T V,Korytina G .2023 .Integrating Common Risk Factors with Polygenic Scores Improves the Prediction of Type 2 Diabetes. Int J Mol Sci, 24(2) : 984.
Elemam NM,Hannawi S,Maghazachi AA .2020 .Role of chemokines and chemokine receptors in rheumatoid arthritis. Immunotargets Ther, 9 : 43-56.
Marques P,Collado A,Martinez-Hervas S,Domingo E,Benito E,Piqueras L .2019 .Systemic inflammation in metabolic syndrome: increased platelet and leukocyte activation, and key role of CX3CL1/CX3CR1 and CCL2/CCR2 axes in arterial platelet-proinflammatory monocyte adhesion. J Clin Med, 8(5) : 708.
Panigrahi S,Chen B,Fang M,Potashnikova D,Komissarov AA,Lebedeva A .2020 .CX3CL1 and IL-15 Promote CD8 T cell chemoattraction in HIV and in atherosclerosis. PLoS Pathog, 16(9) : e1008885.
Zhou B,Xu H,Ni K,Ni X,Shen J .2016 .Expression of chemokine XCL2 and CX3CL1 in lung cancer. Med Sci Monit Int Med J Exp Clin Res, 22 : 1560.
Bronisz E,Cudna A,Wierzbicka A,Kurkowska-Jastrzębska I .2023 .Blood-Brain Barrier-Associated Proteins Are Elevated in Serum of Epilepsy Patients. Cells, 12(3) : 368.
Suleymanova EM,Karan AA,Borisova MA,Volobueva MN,Bolshakov AP .2023 .Expression of Cytokines and Neurodegeneration in the Rat Hippocampus and Cortex in the Lithium-Pilocarpine Model of Status Epilepticus and the Role of Modulation of Endocannabinoid System. Int J Mol Sci, 24(7) : 6509.
0

Citations

0

Downloads

59

Views